Valsartan in Acute Myocardial Infarction Trial Investigators - VALIANT


The goal of the trial was to evaluate the effect of the angiotensin-receptor blocker (ARB) valsartan, the angiotensin-converting enzyme (ACE) inhibitor captopril, and the combination of the two on mortality in patients with myocardial infarction (MI) complicated by left ventricular (LV) systolic dysfunction, heart failure, or both.